Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) FCF Margin (2020 - 2022)

Historic FCF Margin for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to 2597344.18%.

  • Immuneering's FCF Margin fell 25924641800.0% to 2597344.18% in Q4 2022 from the same period last year, while for Sep 2023 it was 10809489.45%, marking a year-over-year decrease of 108011355900.0%. This contributed to the annual value of 14148.44% for FY2022, which is 126622700.0% down from last year.
  • According to the latest figures from Q4 2022, Immuneering's FCF Margin is 2597344.18%, which was down 25924641800.0% from 28701.08% recorded in Q3 2022.
  • Over the past 5 years, Immuneering's FCF Margin peaked at 511.54% during Q3 2020, and registered a low of 2597344.18% during Q4 2022.
  • Moreover, its 3-year median value for FCF Margin was 3378.13% (2021), whereas its average is 265287.05%.
  • In the last 5 years, Immuneering's FCF Margin crashed by -13647100bps in 2021 and then crashed by 2000000000bps in 2022.
  • Quarter analysis of 3 years shows Immuneering's FCF Margin stood at 825.64% in 2020, then crashed by -491bps to 4880.0% in 2021, then crashed by -53124bps to 2597344.18% in 2022.
  • Its last three reported values are 2597344.18% in Q4 2022, 28701.08% for Q3 2022, and 10182.56% during Q2 2022.